Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)
Status:
Terminated
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This is a phase I multicenter, open label study in previously untreated and elderly patients
(> 60 years) with CLL: a non-comparative phase aimed at defining the MTD of lenalidomide
given in combination with chlorambucil and the efficacy and safety of the lenalidomide and
chlorambucil combination.